level-one heading

Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
USD 30 /hr
Hire Dr. Caddie L.
United States
USD 30 /hr

Pathologist & Scientist | Digital Pathology | Immunohistochemistry | Cytopathology| Tissue annotations| Medical writing

Profile Summary
Subject Matter Expertise
Services
Writing Medical Writing, Creative Writing, Translation
Research Scientific and Technical Research
Consulting Healthcare Consulting, Scientific and Technical Consulting
Data & AI Image Analysis
Work Experience

Medical Doctor (Pathologist)

Cells

November 2024 - Present

Researcher investigator

University of Texas MD Anderson Cancer Center

April 2019 - Present

Cytopathologist

Instituto de Patología y Biología Molecular Arias-Stella

2017 - 2019

Teacher assistant

Universidad Peruana de Ciencias Aplicadas

2017 - 2018

Cytopathologist

Hospital Nivel IV Guillermo Almenara Irigoyen

2015 - 2017

Hospital de Emergencias Grau

2015 - 2016

Pathology medical Resident

Hospital Nacional Arzobispo Loayza

2012 - 2015

Member at Medical Education Committee

Colegio Médico del Perú Consejo Nacional

2012 - 2013

medical doctor

Ministerio de Salud

May 2010 - May 2011

medical doctor

Ministerio de Salud

May 2010 - May 2011

Education

Pathologist

Universidad Nacional Mayor de San Marcos

2012 - 2015

Medical Doctor

Universidad Ricardo Palma

2002 - 2010

Certifications
  • MD

    Educational commission for foreign medical graduates

    January 2025 - Present

  • Certification in Anatomic Pathology

    San Marcos University

    July 2015 - Present

  • MD

    Ricardo Palma University

    March 2011 - Present

Publications
JOURNAL ARTICLE
Caddie Laberiano-Fernandez, Qiong Gan, Sophia Mei Wang, Auriole Tamegnon, Ignacio Wistuba, Esther Yoon, Sinchita Roy-Chowdhuri, Edwin Roger Parra (2024). Exploratory pilot study to characterize the immune landscapes of malignant pleural effusions and their corresponding primary tumors from patients with breast carcinoma and lung adenocarcinoma . Journal of the American Society of Cytopathology.
Caddie Laberiano-Fernandez, Camila Machado Baldavira, Juliana Machado-Rugolo, Auriole Tamegnon, Renganayaki Krishna Pandurengan, Alexandre Muxfeldt Ab’Saber, Marcelo Luiz Balancin, Teresa Yae Takagaki, Maria Aparecida Nagai, Vera Luiza Capelozzi, et al. (2023). The Immunological Landscape of M1 and M2 Macrophages and Their Spatial Distribution in Patients with Malignant Pleural Mesothelioma . Cancers.
Caddie Laberiano-Fernandez, Camila Machado Baldavira, JULIANA MACHADO-RUGOLO, Auriole Tamegnon, Renganayaki Krishna Pandurengan, Alexandre Muxfeldt Ab’Saber, Marcelo Balancin, Teresa Takagaki, Maria Aparecida Nagai, VERA LUIZA CAPELOZZI, et al. (2023). The Immunological Landscape of M1 and M2 Macrophages and Their Spatial Distribution in Patients with Malignant Pleural Mesothelioma . Cancers.
Baohua Sun, Caddie Laberiano-Fernández, Ruth Salazar-Alejo, Jiexin Zhang, Jose Luis Solorzano Rendon, Jack Lee, Luisa Maren Solis Soto, Ignacio Ivan Wistuba, Edwin Roger Parra (2023). Impact of Region-of-Interest Size on Immune Profiling Using Multiplex Immunofluorescence Tyramide Signal Amplification for Paraffin-Embedded Tumor Tissues . Pathobiology.
Rama Soundararajan, Paul Viscuse, Patrick Pilie, Jingjing Liu, Souzana Logotheti, Caddie Laberiano Fernández, Daniele Lorenzini, Anh Hoang, Wei Lu, Luisa Maren Solis Soto, et al. (2022). Genotype-to-Phenotype Associations in the Aggressive Variant Prostate Cancer Molecular Profile (AVPC-m) Components . Cancers.
Frank Rojas and Sharia Hernandez and Rossana Lazcano and Caddie Laberiano-Fernandez and Edwin Roger Parra(2022). Multiplex Immunofluorescence and the Digital Image Analysis Workflow for Evaluation of the Tumor Immune Environment in Translational Research . Frontiers in Oncology. 12. Frontiers Media {SA}
Edwin Roger Parra and Jiexin Zhang and Mary Redman and Rossana Lazcano and Piubelli Mario and Caddie Laberiano Fernandez and Renganayaki K. Krishna and Shanyu Zhang and Hong Chen and Ganiraju Manyam and Radim Moravec and Ethan Cerami and James Lindsay and Joyce Yu and Roshni Biswas and Stephen Van Nostrand and Dzifa Y. Duose and Jianjun Zhang and Roy Herbst and Gheath Al-Atrash and Kasthuri Kannan and Ignacio I. Wistuba and Scott Gettinger and Lyudmila Bazhenova and Jack Lee and Jianhua Zhang and Cara Haymaker(2022). Abstract 2580: Infiltration and spatial distribution of immune cells are associated clinical benefit from Nivolumab and Ipilimumab for previously treated patients with stage IV squamous cell lung cancer: an immune biomarker analysis of Phase III SWOG LungMAP S1400I trial . Cancer Research. 82. (12{\_}Supplement). p. 2580--2580. American Association for Cancer Research ({AACR})
Edwin R. Parra and Dzifa Yawa Duose and Jiexin Zhang and Mary Weber Redman and Rossana Lazcano Segura and Mario L. Marques-Piubelli and Caddie Laberiano Fernandez and BaiLi Zhang and James Lindsay and Radim Moravec and Kasthuri Kannan and Rajyalakshmi Luthra and Gheath Alatrash and Roy S. Herbst and Ignacio Ivan Wistuba and Scott N. Gettinger and Lyudmila Bazhenova and J. Jack Lee and Jianjun Zhang and Cara L. Haymaker(2022). Multiomics profiling and association with molecular and immune features in association with benefits from immunotherapy for patients with previously treated stage IV or recurrent squamous cell lung cancer from the phase III SWOG LungMAP S1400I trial . Journal of Clinical Oncology. 40. (16{\_}suppl). p. 9046--9046. American Society of Clinical Oncology ({ASCO})
Rama Soundararajan, Paul Viscuse, Patrick Pilie, Jingjing Liu, Souzana Logotheti, Caddie Laberiano-Fernandez, Daniele Lorenzini, Anh Hoang, Wei Lu, Luisa Solis Soto, et al. (2022). Genotype-to-Phenotype Associations in the Aggressive Variant Prostate Cancer Molecular Profile (AVPC-m) Components . Cancers.
Baohua Sun and Caddie Laberiano-Fern{\'{a}}ndez and Ruth Salazar-Alejo and Jiexin Zhang and Jose Luis Solorzano Rendon and Jack Lee and Luisa Maren Solis Soto and Ignacio Ivan Wistuba and Edwin Roger Parra(2022). Impact of Region-of-Interest Size on Immune Profiling Using Multiplex Immunofluorescence Tyramide Signal Amplification for Paraffin-Embedded Tumor Tissues . Pathobiology. p. 1--12. S. Karger {AG}
Caddie Dy Laberiano and Edwin Parra and Qiong Gan and Heladio Ibarguen and Shanyu Zang and Esther Yoon(2021). 945 Characterization of the immune landscape of malignant pleural effusion composition from patients with metastatic breast carcinoma: a pilot study . Journal for ImmunoTherapy of Cancer. 9. (Suppl 2). p. A993--A994. {BMJ}
Caddie Laberiano-Fernandez and Milagros Abad-Licham and Mauro Saieg and Ana Ja{\'{e}}n and Bruno Dornelas(2021). Diagnosis of Cytopathology Practice in Latin America: A Current Vision . Journal of the American Society of Cytopathology. 10. (5). p. S11--S12. Elsevier {BV}
Jose A. Karam and Pavlos Msaouel and Surena F. Matin and Matthew T Campbell and Amado J. Zurita and Amishi Yogesh Shah and Ignacio Ivan Wistuba and Cara L. Haymaker and Enrica Marmonti and Dzifa Yawa Duose and Edwin R. Parra and Luisa Maren Solis and Caddie Laberiano and Marisa Lozano and Alice Abraham and Max Hallin and Peter Olson and Hirak Der-Torossian and Nizar M. Tannir and Christopher G. Wood(2021). A phase II study of sitravatinib (Sitra) in combination with nivolumab (Nivo) in patients (Pts) undergoing nephrectomy for locally-advanced clear cell renal cell carcinoma (accRCC) . Journal of Clinical Oncology. 39. (6{\_}suppl). p. 312--312. American Society of Clinical Oncology ({ASCO})
Hernandez, S., Rojas, F., Laberiano, C., Lazcano, R., Wistuba, I., Parra, E.R.(2021). Multiplex Immunofluorescence Tyramide Signal Amplification for Immune Cell Profiling of Paraffin-Embedded Tumor Tissues . Frontiers in Molecular Biosciences. 8.
Lazcano, R., Rojas, F., Laberiano, C., Hernandez, S., Parra, E.R.(2021). Pathology Quality Control for Multiplex Immunofluorescence and Image Analysis Assessment in Longitudinal Studies . Frontiers in Molecular Biosciences. 8.
Laberiano-Fernández, C., Hernández-Ruiz, S., Rojas, F., Parra, E.R.(2021). Best Practices for Technical Reproducibility Assessment of Multiplex Immunofluorescence . Frontiers in Molecular Biosciences. 8.
Milagros Abad-Licham and Juan Astigueta and Caddie Laberiano Fern{\'{a}}ndez and Himelda Ch{\'{a}}vez Torres and Grisnery Maquera Torres and Edwin Figueroa and Ricardo Bardales(2020). Interventional cytopathology and cancer in Peru: how to act during COVID-19? . ecancermedicalscience. 14. Ecancer Global Foundation
Caddie Dy Laberiano Fern{\'{a}}ndez(2020). Estado del tamizaje del cáncer de cérvix en países de América Latina desde la perspectiva de los profesionales de salud . Revista Peruana de Ginecología y Obstetricia. 66. (1). p. 37--40. Sociedad Peruana de Obstetricia y Ginecologia
Caddie Laberiano, Edwin Roger Parra, Mei Jiang, Luisa Solis, Barbara Mino, Sharia Hernandez, Swati Gite, Anuj Verma, Michael Tetzlaff, Cara Haymaker, et al. (2020). Procedural Requirements and Recommendations for Multiplex Immunofluorescence Tyramide Signal Amplification Assays to Support Translational Oncology Studies . Cancers.
Parra, E.R., Jiang, M., Solis, L., Mino, B., Laberiano, C., Hernandez, S., Gite, S., Verma, A., Tetzlaff, M., Haymaker, C., et al.(2020). Procedural requirements and recommendations for multiplex immunofluorescence tyramide signal amplification assays to support translational oncology studies . Cancers. 12. (2).
Aguilar, C., Laberiano, C., Beltran, B., Diaz, C., Taype-Rondan, A., Castillo, J.J.(2020). Clinicopathologic characteristics and survival of patients with primary effusion lymphoma . Leukemia and Lymphoma. 61. (9). p. 2093-2102.
Caddie Laberiano and Cristian Aguilar and Cecilia D{\'{\i}}az(2019). Site of Effusion Is an Independent Prognostic Factor for Survival in Patients with Primary Effusion Lymphoma . Journal of the American Society of Cytopathology. 8. (5). p. S7. Elsevier {BV}
Jose A. Karam(2019). Phase II study of sitravatinib in combination with nivolumab in patients undergoing nephrectomy for locally-advanced clear cell renal cell carcinoma (ccRCC) . Journal of Clinical Oncology. 37. (7{\_}suppl). p. TPS686--TPS686. American Society of Clinical Oncology ({ASCO})
(2017). Cyto-histological correlation of ASC-H at Hospital Nacional Guillermo Almenara Irigoyen, January 2013 - July 2015. Revista Peruana de Ginecología y Obstetricia.
(2015). Simultaneous papillary and medullary thyroid carcinoma. Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo.
(2014). Primary angiosarcoma of the breast. Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo.
(2012). • Medical Woman's Role: International Women's Day. Acta Médica.
(2012). Health Literacy: an opportunity to improve the health of the population.
(2012). • Necessity to consider Health Problems in Elderly people: SERUMS experience. Revista del Cuerpo médico Hospital Nacional Almanzor Aguinaga Asenjo.
(2012). • “Tumi” History: Symbol of Peruvian Medicine and Peruvian Medical Association. Acta Médica peruana.
CONFERENCE POSTER
Caddie Laberiano and Luisa Solis and Sinchita Roy Chowdhuri and Edwin Parra(2020). 670 Develop a multiplex immunofluorescence panel to identification of distinct complex immune landscapes in pleural effusion liquids from patients with metastatic lung adenocarcinoma . Regular and young investigator award abstracts. {BMJ} Publishing Group Ltd
Rama Soundararajan and Petra den Hollander and Peter Shepherd and Nora Navone and Daniele Lorenzini and Caddie Laberiano-Fernandez and Wei Lu and Jianling Zhou and Jingjing Liu and Jianhua Zhang and Luisa Maren Solis-Soto and Sendurai A. Mani and Ana Aparicio(2020). Abstract 5443: Modulating plasticity in aggressive variant prostate cancers . Clinical Research (Excluding Clinical Trials). American Association for Cancer Research